Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 06 2021
Historique:
received: 14 11 2020
accepted: 20 05 2021
entrez: 19 6 2021
pubmed: 20 6 2021
medline: 3 11 2021
Statut: epublish

Résumé

Chronic obstructive pulmonary disease (COPD) is a destructive inflammatory disease and the genes expressed within the lung are crucial to its pathophysiology. We have determined the RNAseq transcriptome of bronchial brush cells from 312 stringently defined ex-smoker patients. Compared to healthy controls there were for males 40 differentially expressed genes (DEGs) and 73 DEGs for females with only 26 genes shared. The gene ontology (GO) term "response to bacterium" was shared, with several different DEGs contributing in males and females. Strongly upregulated genes TCN1 and CYP1B1 were unique to males and females, respectively. For male emphysema (E)-dominant and airway disease (A)-dominant COPD (defined by computed tomography) the term "response to stress" was found for both sub-phenotypes, but this included distinct up-regulated genes for the E-sub-phenotype (neutrophil-related CSF3R, CXCL1, MNDA) and for the A-sub-phenotype (macrophage-related KLF4, F3, CD36). In E-dominant disease, a cluster of mitochondria-encoded (MT) genes forms a signature, able to identify patients with emphysema features in a confirmation cohort. The MT-CO2 gene is upregulated transcriptionally in bronchial epithelial cells with the copy number essentially unchanged. Both MT-CO2 and the neutrophil chemoattractant CXCL1 are induced by reactive oxygen in bronchial epithelial cells. Of the female DEGs unique for E- and A-dominant COPD, 88% were detected in females only. In E-dominant disease we found a pronounced expression of mast cell-associated DEGs TPSB2, TPSAB1 and CPA3. The differential genes discovered in this study point towards involvement of different types of leukocytes in the E- and A-dominant COPD sub-phenotypes in males and females.

Identifiants

pubmed: 34145303
doi: 10.1038/s41598-021-91742-x
pii: 10.1038/s41598-021-91742-x
pmc: PMC8213687
doi:

Substances chimiques

Biomarkers 0
KLF4 protein, human 0
Kruppel-Like Factor 4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12848

Références

Eur Respir J. 2012 Oct;40(4):823-9
pubmed: 22441733
Sci Rep. 2017 Mar 13;7:44232
pubmed: 28287180
Am J Respir Crit Care Med. 2003 Feb 15;167(4):570-9
pubmed: 12480607
Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1055-60
pubmed: 8887607
Viruses. 2011 May;3(5):520-40
pubmed: 21994744
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Blood. 1991 Dec 1;78(11):2791-808
pubmed: 1720034
J Inflamm. 1995;45(3):143-51
pubmed: 8597869
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Blood. 2010 Nov 25;116(22):4404-14
pubmed: 20616217
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1125-32
pubmed: 22837375
Respiration. 2012;83(5):383-90
pubmed: 21832824
Am J Physiol. 1994 Mar;266(3 Pt 1):L278-86
pubmed: 8166297
Hum Genomics. 2011 Oct;5(6):691-702
pubmed: 22155607
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Int J Chron Obstruct Pulmon Dis. 2020 Apr 01;15:711-721
pubmed: 32280209
Cancer Res. 2006 May 1;66(9):4645-51
pubmed: 16651415
BMC Genomics. 2012 Feb 29;13:82
pubmed: 22375630
Am J Respir Crit Care Med. 2013 May 1;187(9):933-42
pubmed: 23471465
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1413-7
pubmed: 9603116
Eur Respir J. 2016 Jul;48(1):92-103
pubmed: 27230444
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Mol Med. 2011;17(7-8):762-70
pubmed: 21327296
Nat Rev Immunol. 2013 May;13(5):362-75
pubmed: 23558889
Science. 2020 Sep 11;369(6509):
pubmed: 32913072
Blood. 1992 Sep 1;80(5):1105-15
pubmed: 1381234
Nucleic Acids Res. 2016 Jul 8;44(W1):W83-9
pubmed: 27098042
Adv Immunol. 1994;55:97-179
pubmed: 8304236
Int J Genomics. 2015;2015:206937
pubmed: 25834810
PLoS One. 2014 May 15;9(5):e97491
pubmed: 24830457
Crit Care Med. 2007 Jun;35(6):1464-9
pubmed: 17452928
Nat Rev Immunol. 2008 Sep;8(9):737-44
pubmed: 18728636
Prog Nucleic Acid Res Mol Biol. 2003;74:1-36
pubmed: 14510072
J Biol Chem. 1995 Nov 10;270(45):27136-42
pubmed: 7592968

Auteurs

Anna Esteve-Codina (A)

CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Thomas P Hofer (TP)

EvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany.
Immunoanalytics-Core Facility, Helmholtz Zentrum Muenchen, Munich, Germany.

Dorothe Burggraf (D)

EvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany.

Marion S Heiss-Neumann (MS)

EvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany.

Wolfgang Gesierich (W)

EvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany.

Anne Boland (A)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, Evry, France.

Robert Olaso (R)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, Evry, France.

Marie-Therese Bihoreau (MT)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, Evry, France.

Jean-Francois Deleuze (JF)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, Evry, France.

Winfried Moeller (W)

Institute for Lung Biology and Disease, Helmholtz Zentrum Muenchen, Neuherberg-Munich, Germany.

Otmar Schmid (O)

Institute for Lung Biology and Disease, Helmholtz Zentrum Muenchen, Neuherberg-Munich, Germany.

María Soler Artigas (M)

CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Kathrin Renner (K)

Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.

Jens M Hohlfeld (JM)

Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Hannover, Germany.

Tobias Welte (T)

Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Hannover, Germany.

Thomas Fuehner (T)

Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Hannover, Germany.

Lukas Jerrentrup (L)

Member of the German Center for Lung Research (DZL), Marburg, Germany.
Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University, Marburg, Germany.

Andreas Rembert Koczulla (AR)

Member of the German Center for Lung Research (DZL), Marburg, Germany.
Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University, Marburg, Germany.

Timm Greulich (T)

Member of the German Center for Lung Research (DZL), Marburg, Germany.
Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University, Marburg, Germany.

Antje Prasse (A)

Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Hannover, Germany.

Joachim Müller-Quernheim (J)

Department of Pneumology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Sumit Gupta (S)

Institute for Lung Health, NIHR Leicester BRC, University of Leicester, Leicester, UK.

Christopher Brightling (C)

Institute for Lung Health, NIHR Leicester BRC, University of Leicester, Leicester, UK.

Deepak R Subramanian (DR)

Department of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

David G Parr (DG)

Department of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

Umme Kolsum (U)

Medicines Evaluation Unit, University of Manchester, University Hospital of South Manchester Foundations Trust, Manchester, UK.

Vandana Gupta (V)

Medicines Evaluation Unit, University of Manchester, University Hospital of South Manchester Foundations Trust, Manchester, UK.

Imre Barta (I)

Department of Pathophysiology, National Koranyi Institute for TB and Pulmonology, Budapest, Hungary.

Balázs Döme (B)

Department of Tumorbiology, National Koranyi Institute for TB and Pulmonology, Budapest, Hungary.

János Strausz (J)

Department of Pneumology, National Koranyi Institute for TB and Pulmonology, Budapest, Hungary.

Mariarita Stendardo (M)

Department of Medical Sciences, University of Ferrara and Ferrara City Hospital, Ferrara, Italy.

Marco Piattella (M)

Department of Medical Sciences, University of Ferrara and Ferrara City Hospital, Ferrara, Italy.

Piera Boschetto (P)

Department of Medical Sciences, University of Ferrara and Ferrara City Hospital, Ferrara, Italy.

Damian Korzybski (D)

2nd Department of Respiratory Medicine, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

Dorota Gorecka (D)

2nd Department of Respiratory Medicine, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

Adam Nowinski (A)

2nd Department of Respiratory Medicine, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

Marc Dabad (M)

CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Marcos Fernández-Callejo (M)

CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

David Endesfelder (D)

ICT Department, Helmholtz Zentrum Muenchen, Munich, Germany.

Wolfgang Zu Castell (W)

Department Strategy & Digitalization, Helmholtz Zentrum Muenchen, Munich, Germany.
Faculty of Mathematics, Technical University of Munich, Munich, Germany.

Pieter S Hiemstra (PS)

Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.

Per Venge (P)

Department of Medical Sciences, University of Uppsala, Uppsala, Sweden.

Elfriede Noessner (E)

Immunoanalytics-Tissue Control of Immunocytes, Helmholtz Zentrum Muenchen, Munich, Germany.

Thasso Griebel (T)

CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Simon Heath (S)

CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Dave Singh (D)

Medicines Evaluation Unit, University of Manchester, University Hospital of South Manchester Foundations Trust, Manchester, UK.

Ivo Gut (I)

CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Loems Ziegler-Heitbrock (L)

EvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany. Loems-EvA@gmx.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH